aptsap vectors dna synthesis and codon optimization for mammalian cell expression (GenScript corporation)
Structured Review
![Schematic representation of <t>APTSAP,</t> <t>APTSAPKQ</t> and pBlue_SAP DNA sequences. The nucleotide sequence of AS1411 [5′-d (GGTGGTGGTGGTTGTGGTGGTGGTGG)-3] was placed at the 5′ terminus of a synthetic construct containing the CMV promoter, the saporin gene, a chimeric intron derived from pCI vector, and a poly-adenylation signal at the 3′ terminus and inserted into pBluescript II KS (+) vector using a SmaI restriction site. In the APTSAPKQ construct the saporin gene sequence was substituted with the saporin KQ mutated sequence. The pBlue_SAP construct lacks the 5′ AS1411 aptamer sequence. In the scheme we also indicated the PCR primers at their relative positions (FW1/RV1, FW2/RV2, FW3/RV3). This map was created by the SnapGene Viewer freeware software (“SnapGene software” from Insightful Science; available at http://snapgene.com ).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2512/pmc08082512/pmc08082512__fphar-12-588306-g001.jpg)
Aptsap Vectors Dna Synthesis And Codon Optimization For Mammalian Cell Expression, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aptsap vectors dna synthesis and codon optimization for mammalian cell expression/product/GenScript corporation
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells"
Article Title: Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells
Journal: Frontiers in Pharmacology
doi: 10.3389/fphar.2021.588306
Figure Legend Snippet: Schematic representation of APTSAP, APTSAPKQ and pBlue_SAP DNA sequences. The nucleotide sequence of AS1411 [5′-d (GGTGGTGGTGGTTGTGGTGGTGGTGG)-3] was placed at the 5′ terminus of a synthetic construct containing the CMV promoter, the saporin gene, a chimeric intron derived from pCI vector, and a poly-adenylation signal at the 3′ terminus and inserted into pBluescript II KS (+) vector using a SmaI restriction site. In the APTSAPKQ construct the saporin gene sequence was substituted with the saporin KQ mutated sequence. The pBlue_SAP construct lacks the 5′ AS1411 aptamer sequence. In the scheme we also indicated the PCR primers at their relative positions (FW1/RV1, FW2/RV2, FW3/RV3). This map was created by the SnapGene Viewer freeware software (“SnapGene software” from Insightful Science; available at http://snapgene.com ).
Techniques Used: Sequencing, Construct, Derivative Assay, Plasmid Preparation, Software
Figure Legend Snippet: Dose-response curves showing respectively the effects of ssAPT, APTSAP, APTSAPKQ, pBlue_SAP and pBluescript II KS (+) on U87MG cells. Cells (1.6 × 10 3 /well) were seeded in 96-well plates in a final volume of 200 µl of medium (5% FBS) containing the appropriate concentrations (0, 0.001, 0.01, 1, 10, 50 μmol/L) of ssAPT or the appropriate concentrations (0, 0.001, 0.01, 0.02, 0.05 and 0.1 μmol/L) of APTSAP, APTSAPKQ, pBlue_SAP and pBluescript II KS (+) for 96 h. All the plasmids were denatured at 95°C for 2 min in 10 mM Tris/HCl buffer pH 7.5 containing 100 mM NaCl and 2.5 mM KCl immediately before use. Cell viability was examined using a MTS assay and expressed as percentage of control untreated cells. ssAPT IC 50 : 4.30 × 10 −6 ± 1.70 × 10 −6 M (mean ± S.E.M.); APTSAP IC 50 : 1.30 × 10 −8 ± 2.42×10 −9 M (mean ± S.E.M.). The data reported are representative of a set of at least three independent experiments and are reported as mean ± SD.
Techniques Used: MTS Assay, Control
Figure Legend Snippet: Representative images observed with an optical microscope of U87 cells after 96h of treatment. Controls (A) ; ssAPT 25 µM (B) ; APTSAP 20 nM (C) ; APTSAPKQ 20 nM (D) ; pBlue_SAP 20 nM (E) .
Techniques Used: Microscopy
Figure Legend Snippet: Dose-response curves showing respectively the effect of ssAPT, APTSAP, APTSAPKQ, pBlue_SAP and pBluescript II KS (+) on control NIH3T3 cells. Cells (1.6 × 10 3 /well) were seeded in 96-well plates in a final volume of 200 ul of medium (5% FBS) containing appropriate concentrations (0, 0.001, 0.01, 1, 10, 50 μmol/L) of ssAPT and appropriate concentrations (0, 0.001, 0.01, 0.02, 0.05 and 0.1 μmol/L) of APTSAP, APTSAPKQ, pBlue_SAP and pBluescript II KS (+) and for 96 h. All the plasmids were denatured at 95°C for 2 min in 10 mM Tris/HCl buffer pH 7.5 containing 100 mM NaCl and 2.5 mM KCl immediately before use. Cell viability was examined using a MTS assay and expressed as percentage of control untreated cell. The data presented are representative of a set of at least three independent experiments and are reported as mean ± SD.
Techniques Used: Control, MTS Assay
Figure Legend Snippet: Representative images observed with an optical microscope of NIH3T3 cells after 96 h of treatment. Controls (A) ; ssAPT 25 µM (B) ; APTSAP 20 nM (C) ; APTSAPKQ 20 nM (D) ; pBlue_SAP 20 nM (E) .
Techniques Used: Microscopy
Figure Legend Snippet: U87 (A) and 3T3 cells (B) were treated with 20 nM APTSAP for 96 h, total RNA was extracted from cell pellets. PCR was performed on the corresponding cDNA using the three couples of primers, as described in the Materials and Methods section. pET11d plasmid carrying the wild type saporin gene (pET11d-SAP) was used as a positive control. Amplified products are indicated by arrows, and the expected dimensions are: FW1/RV1:765 bp, FW2/RV2: 204 bp, FW3/RV3: 621bp. Lanes 1-3-5: pET11d-SAP; lanes 2-4-6: treated.
Techniques Used: Plasmid Preparation, Positive Control, Amplification